A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN

Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition. Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Xiao, Wenbin, Miles, Linde A., Bowman, Robert L., Durani, Vidushi, Tian, Helen S., DelGaudio, Nicole L., Mishra, Tanmay, Zhu, Menglei, Zhang, Yanming, Stump, Sarah E., Tallman, Martin S., Levine, Ross L., Cai, Sheng F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Exceptional Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724900/
https://ncbi.nlm.nih.gov/pubmed/33284943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados